Status:
UNKNOWN
Tranexamic Acid in Pediatric Scoliosis Surgery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Scoliosis
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
This study aims to investigate whether intraoperative administration of tranexamic acid based on ROTEM® (Rotational Thromboelastometry), in pediatric patients undergoing scoliosis surgery, results in ...
Eligibility Criteria
Inclusion
- Children undergoing scoliosis surgery under the age of 18
Exclusion
- Patients with coagulation disorders
- Patients at an increased risk of thrombosis
- Patients with a history of epilepsy or brain surgery
- Patients with a previous allergic reaction or anaphylaxis history to tranexamic acid
- Severe liver or kidney impairment
- Other cases deemed inappropriate by the researcher
Key Trial Info
Start Date :
October 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06091891
Start Date
October 16 2023
End Date
September 1 2025
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul national university hospital
Seoul, South Korea, 03080